HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) web only appendix All Versions of this Article: jnnp.2007.118588v1 79/7/767    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Google Scholar Articles by Hoffmann, L A Articles by Voltz, R PubMed PubMed Citation Articles by Hoffmann, L A Articles by Voltz, R Topic Collections Relevant Article

Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases

¹ Institute of Clinical Neuroimmunology, Ludwig-Maximilians-University, Munich, Germany
² Institute of Neuropathology, University of Goettingen, Germany
³ Department of Laboratory Medicine, University Hospital, Cologne, Germany
⁴ Department of Nuclear Medicine, Ludwigs-Maximilians-University, Munich, Germany
⁵ Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, UK
⁶ Department of Palliative Medicine, University Hospital, Cologne, Germany

Correspondence to:
Professor R Voltz, Department of Palliative Medicine, University of Cologne, Kerpener Str 62, 50924 Köln, Germany; raymond.voltz{at}uk-koeln.de

Background: Paraneoplastic neurological syndromes (PNS) are indirect remote effects of cancer on the nervous system, often associated with the presence of specific serum antibodies. The most recently described PNS defining reactivity is anti-Ma/anti-Ta. Here we present 22 newly diagnosed patients with anti-Ma or anti-Ta reactivity, refine the associated clinical picture and review all published patients to date.

Patients and methods: Patients were identified by testing for PNMA1 and PNMA2 antibodies by western blotting and indirect immunofluorescence. Clinical data were obtained either by referral of the patient or from the referring physicians.

Results: Analysis of 22 new patients (14 anti-Ma, eight anti-Ta) confirmed that anti-Ta are usually found in young men with limbic encephalitis and testicular germ cell tumours who stabilise neurologically with long term survival after tumour treatment. Patients with anti-Ma were of either sex, middle-aged, presented with a range of tumours and neurological symptoms and had a limited response to treatment. Furthermore, we expanded the range of associated clinical features: (1) the peripheral nervous system may be involved; (2) an overlap with anti-Hu is possible; and (3) testicular tumour manifestation can be extragonadal or detectable only at orchiectomy.

Conclusion: Refining and expanding the range of anti-Ma/anti-Ta associated neurological presentations and tumours clearly demonstrated that the distinction between anti-Ma and anti-Ta associated PNS is of high clinical relevance.

This article has been cited by other articles:

				J. Verschuuren Hu, Yo, Ri, Ma, Ta: monosyllabic answers to complex questions J. Neurol. Neurosurg. Psychiatry, July 1, 2008; 79(7): 742 - 742. [Full Text] [PDF]